Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/AR/Fayetteville
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Fayetteville, AR

Studies commonly pay $75 to $4,500 per completed study

126 clinical trials are currently recruiting participants within 30 miles of Fayetteville. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

126studies recruiting
9+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Fayetteville right now

Top 25 of 126 recruiting studies, sorted by proximity — each links to its official registry page

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Chronic Migraine Phase 3 Interventional 420 participants sought
Preferred Research Partners - Fayetteville /ID# 270419 — Fayetteville, Arkansas (0.8 mi) · Sponsor: AbbVie

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer Phase 3 Interventional 1,000 participants sought
Highlands Oncology Group, PA — Fayetteville, Arkansas (0.8 mi) · Sponsor: Pfizer

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Non-Small Cell Lung Cancer Phase 3 Interventional 675 participants sought
Research Site — Springdale, Arkansas (8.2 mi) · Sponsor: AstraZeneca

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Metastatic Prostate Cancer Phase 1, Phase 2 Interventional 283 participants sought
Research Site — Fayetteville, Arkansas (0.8 mi) · Sponsor: AstraZeneca

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

Attention-Deficit/Hyperactivity Disorder Phase 4 Interventional 286 participants sought
Preferred Research Partners-NWA, LLC — Fayetteville, Arkansas (0.8 mi) · Sponsor: Supernus Pharmaceuticals, Inc.

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic Phase 3 Interventional 680 participants sought
Highlands Oncology Group, PA — Fayetteville, Arkansas (0.8 mi) · Sponsor: Pfizer

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Oligometastatic Prostate Cancer (OMPC) Phase 3 Interventional 450 participants sought
Highlands Oncology Group — Fayetteville, Arkansas (0.8 mi) · Sponsor: Novartis Pharmaceuticals

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: National Cancer Institute (NCI)

A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)

Muscle-invasive Urothelial Carcinoma Phase 2 Interventional 62 participants sought
Highlands Oncology Group. — Springdale, Arkansas (8.2 mi) · Sponsor: Hoffmann-La Roche

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

Eosinophilic Gastrointestinal Disorders (EGIDs), Eosinophilic Esophagitis N/A Observational 1,350 participants sought
Arkansas Children's Research Institute — Rogers, Arkansas (18.2 mi) · Sponsor: Children's Hospital Medical Center, Cincinnati

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 Phase 3 Interventional 304 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: National Cancer Institute (NCI)

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Metastatic Non-small Cell Lung Cancer Phase 3 Interventional 744 participants sought
Research Site — Fayetteville, Arkansas (0.8 mi) · Sponsor: AstraZeneca

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma, Recurrent Platinum-Sensitive Fallopian Tube High Grade Serous Adenocarcinoma Phase 2 Interventional 87 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: National Cancer Institute (NCI)

The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder

Attention-Deficit/Hyperactivity Disorder Phase 2 Interventional 76 participants sought
University of Arkansas — Fayetteville, Arkansas (0.8 mi) · Sponsor: University of Arkansas, Fayetteville

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Breast Neoplasms, Neoplasm Metastasis Phase 3 Interventional 800 participants sought
Highlands Oncology Group — Springdale, Arkansas (8.2 mi) · Sponsor: Eli Lilly and Company

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Intestinal Neoplasms, Gastrointestinal Neoplasms Phase 3 Interventional 800 participants sought
Highlands Oncology Group — Fayetteville, Arkansas (0.8 mi) · Sponsor: Pfizer

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Major Depressive Disorder Phase 3 Interventional 450 participants sought
Woodland Research Northwest — Rogers, Arkansas (18.2 mi) · Sponsor: Xenon Pharmaceuticals Inc.

A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)

Hidradenitis Suppurativa (HS) Phase 2 Interventional 150 participants sought
Site 119 — Rogers, Arkansas (18.2 mi) · Sponsor: Spyre Therapeutics, Inc.

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Breast Cancer Phase 3 Interventional 625 participants sought
Research Site — Springdale, Arkansas (8.2 mi) · Sponsor: AstraZeneca

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

Bipolar Disorder Type I With Mania or Mania With Mixed Features Phase 3 Interventional 274 participants sought
Woodland Research Northwest — Rogers, Arkansas (18.2 mi) · Sponsor: Bristol-Myers Squibb

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma Phase 3 Interventional 700 participants sought
Highlands Oncology Group — Springdale, Arkansas (8.2 mi) · Sponsor: Janssen Research & Development, LLC

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder

Bipolar 1 Disorder Phase 2 Interventional 250 participants sought
Woodland Research Northwest — Rogers, Arkansas (18.2 mi) · Sponsor: Rapport Therapeutics Inc.
Actively enrolling

Studies you may be able to join near Fayetteville

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Fayetteville

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Health Initiatives Research

2233 Green Acres Rd, Fayetteville, AR 72703
(479) 575-9600

Clinical Trials Institute of Northwest Arkansas

1651 E Stearns St #110, Fayetteville, AR 72703
(479) 544-3483

UAMS Northwest Regional Campus

★ 3.8
1125 N College Ave, Fayetteville, AR 72703
(479) 713-8000

The Spero Clinic

★ 4.9 (242 reviews)
22 Colt Square Dr, Fayetteville, AR 72703
(479) 333-8422

Woodland Research Northwest

★ 4.3
609 W Dyke Rd, Rogers, AR 72758
(479) 927-3000

Pat Walker Health Center

★ 3.0
525 Garland Ave, Fayetteville, AR 72701
(479) 575-4451
"The ladies at the front desk are very welcoming and friendly. They are very outgoing and were more than happy to help me. I really appreciate the tim…"
— Miller Johnston, 5★

Pillar Clinical Research, Bentonville, Arkansas

★ 4.9
3200 NE Redhawk Dr, Bentonville, AR 72712
(479) 367-2688
"⭐⭐⭐⭐⭐<br><br>I had a great experience with Pillar Clinical Research. The staff was friendly, professional, and made me feel comfortable from the…"
— elexis Thomas, 5★

C & C Market Research

★ 4.1
4201 N Shiloh Dr #1820, Fayetteville, AR 72703
(479) 582-1127
"Tried calling the number says been disconnected ☹️😡"
— Elizabeth Ritcheson (Bettyjo), 1★

Northwest Arkansas Clinical Trials Center, PLLC

★ 5.0
599 S Horsebarn Rd #200, Rogers, AR 72758
(479) 876-8205

Clinical trials in Fayetteville: what's recruiting

The Fayetteville area currently has 126 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Fayetteville, the most active research areas are:

  • Cancer & Oncology13 studies
  • Brain & Mental Health4 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Fayetteville, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Fayetteville

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Fayetteville participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Fayetteville pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Fayetteville safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Fayetteville?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fayetteville.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Fayetteville typically complete one or two studies per year.

Paid clinical trials near Fayetteville

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of AR

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts